Leaflet FOREXO 200mg film-coated tablets


Indicated for: bacterial infections

Substance: cefpodoxime (cephalosporin antibiotic)

ATC: J01DD13 (Antiinfectives for systemic use | Other beta-lactam antibacterials | Third-generation cephalosporins)

Cefpodoxime is a third-generation cephalosporin antibiotic used to treat bacterial infections, including respiratory infections, skin and soft tissue infections, urinary tract infections, and otitis media. It is effective against a wide range of gram-negative and gram-positive bacteria.

The medication is taken orally, usually twice daily, and the dosage is adjusted based on the severity of the infection and the patient's weight. Cefpodoxime is well-tolerated and is often used in outpatient settings for mild to moderate infections.

Patients should complete the treatment as directed by their doctor to prevent the development of bacterial resistance. It is important to monitor for potential side effects, such as allergic reactions or gastrointestinal disturbances.

Side effects may include nausea, diarrhea, abdominal pain, or, in rare cases, severe allergic reactions. Patients should inform their doctor of any unusual symptoms.

General data about FOREXO 200mg

  • Substance: cefpodoxime
  • Date of last drug list: 01-05-2026
  • Commercial code: W59415002
  • Concentration: 200mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 20
  • Product type: generic
  • Price: 91.26 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: ALKALOID-INT D.O.O. - SLOVENIA
  • Holder: ALKALOID-INT D.O.O. - SLOVENIA
  • Number: 11080/2018/02
  • Shelf life: 2 years

Pharmaceutical forms available for cefpodoxime

Concentrations available for cefpodoxime

  • 100mg
  • 200mg
  • 8mg/ml